1-Year Outcomes With Intracoronary Abciximab in Diabetic Patients Undergoing Primary Percutaneous Coronary Intervention

  1. Piccolo, R. 1
  2. Eitel, I. 2
  3. Galasso, G. 3
  4. Dominguez-Rodriguez, A. 4
  5. Iversen, A.Z. 5
  6. Abreu-Gonzalez, P. 6
  7. Windecker, S. 1
  8. Thiele, H. 2
  9. Piscione, F. 3
  1. 1 University Hospital of Bern
    info

    University Hospital of Bern

    Berna, Suiza

    GRID grid.411656.1

  2. 2 University of Lubeck
    info

    University of Lubeck

    Lubeca, Alemania

    GRID grid.4562.5

  3. 3 University of Salerno
    info

    University of Salerno

    Fisciano, Italia

    GRID grid.11780.3f

  4. 4 Hospital Universitario de Canarias
    info

    Hospital Universitario de Canarias

    San Cristóbal de La Laguna, España

    GRID grid.411220.4

  5. 5 Copenhagen University Hospital
    info

    Copenhagen University Hospital

    Copenhague, Dinamarca

    GRID grid.4973.9

  6. 6 Universidad de La Laguna
    info

    Universidad de La Laguna

    San Cristobal de La Laguna, España

    GRID grid.10041.34

Journal:
Journal of the American College of Cardiology

ISSN: 1558-3597

Year of publication: 2016

Volume: 68

Issue: 7

Pages: 727-738

Type: Article

Export: RIS
DOI: 10.1016/j.jacc.2016.05.078 PMID: 27515333 SCOPUS: 2-s2.0-84987788621 GOOGLE SCHOLAR lock_openOpen access editor
Data source: Scopus